tlooto
Sign up
SCIESCOPUSQ1

JOURNAL OF DRUG TARGETING

TAYLOR & FRANCIS LTD, United Kingdom

JOURNAL OF DRUG TARGETING is an academic journal published by TAYLOR & FRANCIS LTD (United Kingdom). Identifiers: ISSN 1061-186X, eISSN 1029-2330. Indexed in SCIE, SCOPUS. Metrics: JIF 3.9, CiteScore 8.9, SJR 0.870, SNIP 0.71. Subject areas: PHARMACOLOGY & PHARMACY. tlooto lists 2,878 papers from this journal.

CiteScore

8.90

Scopus citation metric

SJR

0.870

SCImago rank

SNIP

0.71

Source normalized impact

Percentage rank

-

JIF percentile rank

Journal profile

ISSN
1061-186X
eISSN
1029-2330
Abbreviation
J DRUG TARGET
Publisher
TAYLOR & FRANCIS LTD
Country
United Kingdom

Web of Science categories

SCIEPHARMACOLOGY & PHARMACY

Scopus ASJC categories

3003 Pharmaceutical Science

Keywords

Pharmacology & Pharmacy

Papers in this journal

Recent papers

  1. Targeted delivery of Naringenin-enriched mannosylated niosomal nanogel for effective therapy of skin cancer.

    2026

  2. Nanomedicines: An Update of Diagnostic and Therapeutic Applications in Multiple Cancers.

    2026 · 1 citations

  3. Buspirone Hydrochloride: A Potential Regulator of PD-L1 for Enhanced Antitumor Activity in Melanoma-Bearing Mice.

    2026

  4. Advanced co-delivery nanocarriers to overcome drug resistance in breast cancer: carrier-mediated synergistic treatment by chemotherapy and gene therapy.

    2026

  5. Potential role of PVP/poloxamer 407 nanofibers loaded with resveratrol nanocrystals in skin cancer therapy.

    2026

Most cited papers

  1. Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier

    2002 · 787 citations

  2. Nanoparticle Surface Charges Alter Blood–Brain Barrier Integrity and Permeability

    2004 · 703 citations

  3. Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicines

    2007 · 602 citations

  4. Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors.

    1998 · 555 citations

  5. Oral bioavailability of curcumin: problems and advancements

    2016 · 460 citations